CVS Health (CVS) is a top S&P 500 performer in 2025, with year-to-date returns exceeding 50%. Moreover, the stock has shirked ...

CVS Health Inc (NYSE:CVS) on Tuesday named Brian Newman as executive vice president and chief financial officer designate, ...

Brian Newman will guide CVS’ finances at a challenging time for the retail pharmacy and health insurance giant. Still, CVS ...

Leading pharmacy benefit managers are shifting away from lucrative rebates on biologic drugs and toward lower-cost biosimilar ...

The CEOs of CVS Health and UnitedHealth Group praised pharmacy benefit managers and promised transparency during investor ...

Analysts have recently evaluated CVS Health and provided 12-month price targets. The average target is $74.12, accompanied by ...

CVS Health is a BUY. Undervalued with growth potential, it outshines competitors despite sector challenges. See more on CVS ...

The Arkansas House and Senate have approved a bill that would force pharmacy benefit managers from holding a pharmacy license ...

CVS Health CEO David Joyner earned $17.8 million in total compensation in 2024. The company reported compensation data for its six highest-paid executives in its annual proxy report, published April 4 ...

Arkansas lawmakers on both sides of the aisle have come together to file a bill that would stop pharmacy benefit managers—the middlemen who negotiate with insur ...